DCPH · Deciphera Pharmaceuticals
Acquired Company
Ono Pharmaceutical completed its $2.4 billion acquisition of Deciphera Pharmaceuticals on 6/10/2024, acquiring all outstanding shares for $25.60 per share in cash.
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to improve the lives of cancer patients by addressing key drug resistance mechanisms that limit the rate and durability of response to existing cancer therapies. The company is headquartered in Waltham, Massachusetts.
200 SMITH STREET, WALTHAM, MA, UNITED STATES, 02451, Massachusetts, 02451-0099, USA
DRUG MANUFACTURERS - SPECIALTY & GENERIC
HEALTHCARE
Market Cap
2.213B
52 Wk Range
$0.00 - $0.00
Previous Close
$25.59
Open
$25.59
Volume
N/A
Day Range
$25.59 - $25.59
Enterprise Value
N/A
Cash
91.23M
Avg Qtr Burn
-54.59M
Insider Ownership
28.48%
Institutional Own.
72.03%
Qtr Updated
Mar 31st 2024